U.S. FDA Approves Delgocitinib Cream (Anzupgo, LEO Pharma) for Chronic Hand Eczema
The U.S. Food and Drug Administration (FDA) has approved delgocitinib cream (Anzupgo, Leo Pharma) for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in adults who have had an inadequate response to, or for whom topical corticosteroids are not advisable.